Ning Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ning Zhang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Congyi Xie
4 shared publicationsHaiyan Chen
Department of Pulmonary Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China
2 shared publicationsJinzhan Chen
2 shared publications- Jinzhan Chen
Zhongshan Hospital (Xiamen) Fudan University Xiamen China
2 shared publications Shuwen Yang
2 shared publications- Haiyan Chen1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (3) , 225
A clinician-oriented machine learning model for adult asthma exacerbation prediction: comparative analysis of nine algorithms
Asthma exacerbations significantly contribute to morbidity and healthcare burden, yet accurate risk prediction remains challenging. This study aimed to develop and validate a machine learning (ML)-based model to predict the exacerbation risk in adult asthma patients. This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) collected between 2007 and 2012, comprising a cohort of 1,480 adult participants diagnosed with asthma. A total of 37 candidate features were assessed, and feature selection via least absolute shrinkage and selection operator (LASSO) identified seven key predictors. Nine ML models were developed and evaluated using the area under the curve (AUC) to determine the optimal model. The best-performing model underwent further validation using calibration curves, precision-recall (PR) curves, and decision curve analysis (DCA). Shapley Additive Explanations (SHAP) was applied to interpret the model’s predictions. A light gradient boosting machine (LightGBM) model showed the best predictive performance, with an AUC of 0.902 in the training set and comparable discrimination in the validation set. Model performance in the validation cohort showed consistent results across calibration analysis, PR curves, and DCA. Model interpretability was examined using SHAP and a web-based calculator was developed to support individualized risk estimation. This ML-based model demonstrated strong predictive accuracy and could serve as a valuable tool for risk assessment of adult asthma in clinical practice.
- 1 March 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (3) , 225
Open AccessA clinician-oriented machine learning model for adult asthma exacerbation prediction: comparative analysis of nine algorithms
Asthma exacerbations significantly contribute to morbidity and healthcare burden, yet accurate risk prediction remains challenging. This study aimed to develop and validate a machine learning (ML)-based model to predict the exacerbation risk in adult asthma patients. This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) collected between 2007 and 2012, comprising a cohort of 1,480 adult participants diagnosed with asthma. A total of 37 candidate features were assessed, and feature selection via least absolute shrinkage and selection operator (LASSO) identified seven key predictors. Nine ML models were developed and evaluated using the area under the curve (AUC) to determine the optimal model. The best-performing model underwent further validation using calibration curves, precision-recall (PR) curves, and decision curve analysis (DCA). Shapley Additive Explanations (SHAP) was applied to interpret the model’s predictions. A light gradient boosting machine (LightGBM) model showed the best predictive performance, with an AUC of 0.902 in the training set and comparable discrimination in the validation set. Model performance in the validation cohort showed consistent results across calibration analysis, PR curves, and DCA. Model interpretability was examined using SHAP and a web-based calculator was developed to support individualized risk estimation. This ML-based model demonstrated strong predictive accuracy and could serve as a valuable tool for risk assessment of adult asthma in clinical practice.
- Open Access
- 1 October 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8893-8903
Association between age-adjusted visceral adiposity index and obstructive sleep apnea: a study based on NHANES 2015–2018
Background: Obstructive sleep apnea (OSA) is a common sleep disorder that significantly impairs sleep quality and daytime functionality, with a well-established association with obesity. To enhance the precision of OSA risk assessment, this study introduces the age-adjusted visceral adiposity index (AVAI) and investigates its association with OSA. Methods: The study utilized data from the 2015–2018 National Health and Nutrition Examination Survey (NHANES). The association of AVAI with OSA was examined through a multivariate logistic regression model. Propensity score matching (PSM) was leveraged for mitigating baseline characteristic imbalances and validating the robustness of the findings. Interaction and subgroup analyses were conducted to explore potential effect modifiers. In addition, receiver operating characteristic (ROC) curve analysis was performed to evaluate the discriminative ability of AVAI for OSA. Results: Among 3,611 participants, 1,753 were diagnosed with OSA. AVAI was significantly associated with OSA [odds ratio (OR) =1.15, 95% confidence interval (CI): 1.09, 1.21]. Participants in the highest AVAI quartile (Q4) had a notably elevated likelihood of OSA in contrast to those in the lowest quartile (Q1) (OR =2.67, 95% CI: 1.96, 3.64). This relation remained significant in the PSM-adjusted sample (OR =1.14, 95% CI: 1.09, 1.20). Subgroup analyses demonstrated that the link of AVAI to OSA was particularly significant in females, non-hypertensive individuals, non-diabetic individuals, and those without cardiovascular disease. Conclusions: This cross-sectional study establishes AVAI’s independent association with OSA. Clinically, AVAI may help identify current high-risk profiles to guide targeted management, though predictive applications require future validation.
- 1 October 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (10) , 8893-8903
Open AccessAssociation between age-adjusted visceral adiposity index and obstructive sleep apnea: a study based on NHANES 2015–2018
Background: Obstructive sleep apnea (OSA) is a common sleep disorder that significantly impairs sleep quality and daytime functionality, with a well-established association with obesity. To enhance the precision of OSA risk assessment, this study introduces the age-adjusted visceral adiposity index (AVAI) and investigates its association with OSA. Methods: The study utilized data from the 2015–2018 National Health and Nutrition Examination Survey (NHANES). The association of AVAI with OSA was examined through a multivariate logistic regression model. Propensity score matching (PSM) was leveraged for mitigating baseline characteristic imbalances and validating the robustness of the findings. Interaction and subgroup analyses were conducted to explore potential effect modifiers. In addition, receiver operating characteristic (ROC) curve analysis was performed to evaluate the discriminative ability of AVAI for OSA. Results: Among 3,611 participants, 1,753 were diagnosed with OSA. AVAI was significantly associated with OSA [odds ratio (OR) =1.15, 95% confidence interval (CI): 1.09, 1.21]. Participants in the highest AVAI quartile (Q4) had a notably elevated likelihood of OSA in contrast to those in the lowest quartile (Q1) (OR =2.67, 95% CI: 1.96, 3.64). This relation remained significant in the PSM-adjusted sample (OR =1.14, 95% CI: 1.09, 1.20). Subgroup analyses demonstrated that the link of AVAI to OSA was particularly significant in females, non-hypertensive individuals, non-diabetic individuals, and those without cardiovascular disease. Conclusions: This cross-sectional study establishes AVAI’s independent association with OSA. Clinically, AVAI may help identify current high-risk profiles to guide targeted management, though predictive applications require future validation.
- Open Access
- 1 September 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (9) , 6569-6580
Potassium and survival outcomes in asthma patients: evidence from a retrospective cohort study
Background: Asthma is a chronic respiratory disease with multifactorial influences. Although potassium intake has been linked to outcomes in other chronic conditions, its association with all-cause mortality in adults with asthma remains unclear. This study aimed to investigate the association between potassium intake and survival outcomes in patients with asthma. Methods: This retrospective cohort study analyzed data from 6,279 asthma patients in the National Health and Nutrition Examination Survey (NHANES) using weighted methods. Cox proportional hazards regression models were employed to examine the association between potassium and all-cause mortality, with sequential adjustments for demographic characteristics (Model 1), clinical and biochemical factors (Model 2), and comorbidities (Model 3). Kaplan-Meier curves were used to estimate survival probabilities. Subgroup analyses were performed to assess consistency across covariates. Restricted cubic spline (RCS) and threshold analyses were applied to explore non-linear associations and identify intake thresholds. Results: Serum potassium was not significantly associated with all-cause mortality in Models 2 and 3 (P>0.05). In contrast, dietary potassium intake showed a consistent inverse association with mortality across all models. In Model 3, participants in the highest intake quartile had a 37% lower risk of death compared to the lowest quartile [hazard ratio (HR) =0.64; 95% confidence interval (CI): 0.46–0.89; P=0.008]. RCS revealed an inverse relationship, while threshold analysis indicated a reduced mortality risk associated with potassium intake below 3,192 mg/day (HR =0.78; 95% CI: 0.68–0.89; PConclusions: Higher potassium intake was associated with improved survival outcomes in asthma patients, with a threshold effect observed.
- 1 September 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (9) , 6569-6580
Open AccessPotassium and survival outcomes in asthma patients: evidence from a retrospective cohort study
Background: Asthma is a chronic respiratory disease with multifactorial influences. Although potassium intake has been linked to outcomes in other chronic conditions, its association with all-cause mortality in adults with asthma remains unclear. This study aimed to investigate the association between potassium intake and survival outcomes in patients with asthma. Methods: This retrospective cohort study analyzed data from 6,279 asthma patients in the National Health and Nutrition Examination Survey (NHANES) using weighted methods. Cox proportional hazards regression models were employed to examine the association between potassium and all-cause mortality, with sequential adjustments for demographic characteristics (Model 1), clinical and biochemical factors (Model 2), and comorbidities (Model 3). Kaplan-Meier curves were used to estimate survival probabilities. Subgroup analyses were performed to assess consistency across covariates. Restricted cubic spline (RCS) and threshold analyses were applied to explore non-linear associations and identify intake thresholds. Results: Serum potassium was not significantly associated with all-cause mortality in Models 2 and 3 (P>0.05). In contrast, dietary potassium intake showed a consistent inverse association with mortality across all models. In Model 3, participants in the highest intake quartile had a 37% lower risk of death compared to the lowest quartile [hazard ratio (HR) =0.64; 95% confidence interval (CI): 0.46–0.89; P=0.008]. RCS revealed an inverse relationship, while threshold analysis indicated a reduced mortality risk associated with potassium intake below 3,192 mg/day (HR =0.78; 95% CI: 0.68–0.89; PConclusions: Higher potassium intake was associated with improved survival outcomes in asthma patients, with a threshold effect observed.
- Open Access
- 11 April 2025
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 25 (1) , 1-12
Association of eosinophil-to-monocyte ratio with asthma exacerbations in adults: a cross-sectional analysis of NHANES data
The eosinophil-to-monocyte ratio (EMR) has emerged as a promising biomarker for assessing inflammation in various diseases, and this study aims to investigate its potential in predicting asthma exacerbations. This cross-sectional study used data from the National Health and Nutrition Examination Survey (NHANES) 1999–2020. A total of 4,738 adults were included in the analysis, and weighted analyses were performed to ensure a representative sample of the general population. The relationship between EMR and asthma exacerbation risk was assessed using multivariable logistic regression with progressively adjusted covariates across multiple models. Subgroup analyses were performed by stratifying key covariates to explore interactions. Restricted cubic spline (RCS) analysis was applied to evaluate non-linear relationships. Sensitivity analyses confirmed the robustness and reliability of the results. Elevated EMR levels were significantly associated with an increased risk of asthma exacerbations (p < 0.001 in all models). In the highest EMR quartile (Q4), the odds ratio for exacerbation compared to the lowest quartile (Q1) was 1.54 (95% CI: 1.23, 1.93) in Model 1, increasing to 1.56 (95% CI: 1.24, 1.97) in Model 2 and 1.58 (95% CI: 1.24, 2.02) in Model 3, after further adjustments. Subgroup analyses showed consistent associations across various characteristics (all p for interaction > 0.05), while RCS analysis revealed a linear relationship without threshold effects (p for nonlinear > 0.05). EMR demonstrates strong potential as a biomarker for predicting asthma exacerbations, with implications for personalized asthma management.
- 11 April 2025
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 25 (1) , 1-12
Open AccessAssociation of eosinophil-to-monocyte ratio with asthma exacerbations in adults: a cross-sectional analysis of NHANES data
The eosinophil-to-monocyte ratio (EMR) has emerged as a promising biomarker for assessing inflammation in various diseases, and this study aims to investigate its potential in predicting asthma exacerbations. This cross-sectional study used data from the National Health and Nutrition Examination Survey (NHANES) 1999–2020. A total of 4,738 adults were included in the analysis, and weighted analyses were performed to ensure a representative sample of the general population. The relationship between EMR and asthma exacerbation risk was assessed using multivariable logistic regression with progressively adjusted covariates across multiple models. Subgroup analyses were performed by stratifying key covariates to explore interactions. Restricted cubic spline (RCS) analysis was applied to evaluate non-linear relationships. Sensitivity analyses confirmed the robustness and reliability of the results. Elevated EMR levels were significantly associated with an increased risk of asthma exacerbations (p < 0.001 in all models). In the highest EMR quartile (Q4), the odds ratio for exacerbation compared to the lowest quartile (Q1) was 1.54 (95% CI: 1.23, 1.93) in Model 1, increasing to 1.56 (95% CI: 1.24, 1.97) in Model 2 and 1.58 (95% CI: 1.24, 2.02) in Model 3, after further adjustments. Subgroup analyses showed consistent associations across various characteristics (all p for interaction > 0.05), while RCS analysis revealed a linear relationship without threshold effects (p for nonlinear > 0.05). EMR demonstrates strong potential as a biomarker for predicting asthma exacerbations, with implications for personalized asthma management.
- Open Access
- 25 February 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1533514
Protective effect of dietary phosphorus intake on cardiovascular mortality in asthma: evidence from NHANES 1999–2018
Background: Asthma is associated with an increased risk of cardiovascular mortality, potentially influenced by dietary phosphorus intake through its effects on inflammation and oxidative stress.Methods: Data from 7,539 asthma patients in the National Health and Nutrition Examination Survey (NHANES) 1999–2018 cohort were analyzed using weighted Cox proportional hazards models to estimate hazard ratios (HR) and 95% confidence intervals (CI). Kaplan-Meier survival curves and a nomogram were used to assess survival probabilities and individualized risk, while restricted cubic spline (RCS) analysis evaluated non-linear dose-response relationships. Sensitivity analyses were conducted to test the robustness of the findings.Results: Higher dietary phosphorus intake was associated with reduced cardiovascular mortality (HR: 0.43; 95% CI: 0.22–0.85 for the highest vs. lowest quartile; p for trend = 0.018). Kaplan-Meier curves showed improved survival with increasing phosphorus intake, a result consistently supported by subgroup analyses. RCS analysis confirmed a non-linear dose-response relationship, identifying a threshold at 1,861.52 mg/day, below which higher phosphorus intake was significantly associated with lower cardiovascular mortality. However, above this threshold, the protective effect diminished. Sensitivity analyses further validated these results.Conclusion: Elevated dietary phosphorus intake is associated with reduced cardiovascular mortality in asthma patients, suggesting its potential as a dietary intervention.
- 25 February 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1533514
Open AccessProtective effect of dietary phosphorus intake on cardiovascular mortality in asthma: evidence from NHANES 1999–2018
Background: Asthma is associated with an increased risk of cardiovascular mortality, potentially influenced by dietary phosphorus intake through its effects on inflammation and oxidative stress.Methods: Data from 7,539 asthma patients in the National Health and Nutrition Examination Survey (NHANES) 1999–2018 cohort were analyzed using weighted Cox proportional hazards models to estimate hazard ratios (HR) and 95% confidence intervals (CI). Kaplan-Meier survival curves and a nomogram were used to assess survival probabilities and individualized risk, while restricted cubic spline (RCS) analysis evaluated non-linear dose-response relationships. Sensitivity analyses were conducted to test the robustness of the findings.Results: Higher dietary phosphorus intake was associated with reduced cardiovascular mortality (HR: 0.43; 95% CI: 0.22–0.85 for the highest vs. lowest quartile; p for trend = 0.018). Kaplan-Meier curves showed improved survival with increasing phosphorus intake, a result consistently supported by subgroup analyses. RCS analysis confirmed a non-linear dose-response relationship, identifying a threshold at 1,861.52 mg/day, below which higher phosphorus intake was significantly associated with lower cardiovascular mortality. However, above this threshold, the protective effect diminished. Sensitivity analyses further validated these results.Conclusion: Elevated dietary phosphorus intake is associated with reduced cardiovascular mortality in asthma patients, suggesting its potential as a dietary intervention.